Rattus norvegicus
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA105647 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:The molecular mechanisms of progressive right heart failure are incompletely understood. We systematically examined transcriptomic changes occurring over months in isolated cardiomyocytes or whole heart tissues from failing right and left ventricles in rat models of pulmonary artery (PAB) or aortic banding (AOB). Detailed bioinformatics analyses resulted in the identification of gene signatures, protein, and transcription factor networks specific to ventricles and compensated or decompensated disease states. Proteomic and RNA-FISH analyses confirmed PAB-mediated regulation of key genes (including proenkephalin) and revealed spatially heterogeneous mRNA expression in the heart. Intersection of rat PAB-specific gene sets with transcriptome data sets from human patients with chronic thromboembolic pulmonary hypertension led to the identification of more than 50 genes whose expression levels correlated with the severity of right heart disease, including multiple matrix-regulating and secreted factors. These data define a conserved, differentially regulated genetic network associated with right heart failure in rats and humans
2024-04-11 | PXD047022 | Pride
Project description:Rat right heart pulmonary embolism microarray
| PRJNA97549 | ENA
Project description:Rat lung gene expression during acute pulmonary embolism
| PRJNA110709 | ENA
Project description:Gene expression in the chronic ethanol-treated rat liver during liver regeneration
| PRJNA148049 | ENA
Project description:Right ventricular heart failure (RVF) associated with pulmonary hypertension (PH) is characterized by a distinct gene expression pattern when compared with functional compensatory hypertrophy. Carvedilol treatment after RVF has been established reduces right ventricle (RV) hypertrophy and improves the RV function. In addition, carvedilol treatment has been shown to alter the gene expression of select genes. We sought to identify, on a genome-wide basis, the effect of carvedilol on gene expression. RVF was induced in male Sprague-Dawley rats by the combination of VEGF-receptor blockade and chronic hypoxia; thereafter, one group was treated with carvedilol. RNA was isolated from the RV and subjected to microarray analysis. A prediction analysis of the carvedilol-treated RVs showed that carvedilol treated RVs most resembled in their expression pattern the RVF pattern. However, an analysis beyond the boundaries of the prediction set revealed a small set of genes associated with carvedilol reversal of RVF. Pathway analysis of this set of genes revealed expression changes of genes involved in cardiac hypertrophy, mitochondrial dysfunction, protein ubiquitination, and sphingolipid metabolism. Genes encoding proteins in the cardiac hypertrophy and protein ubiquitination pathways were downregulated in the RV by carvedilol, while genes encoding proteins in the mitochondrial dysfunction and sphingolipid metabolism pathways were upregulated by carvedilol.
2013-05-06 | GSE42579 | GEO
Project description:Expression data from rat soleus during chronic intermittent physical inactivity
| PRJNA96513 | ENA
Project description:Expression data from cultured rat right ventricular papillary muscles
| PRJNA193317 | ENA
Project description:miRNA expression during liver regeneration in the chronic ethanol-fed rat
| PRJNA150025 | ENA
Project description:Expression Profiling of DA, COP, and F1(COPxDA) rat left ventricles
| PRJNA90597 | ENA
Project description:Gene expression in the right ventricle of Rattus norvegicus during development of right ventricular heart failure and treatment
| PRJNA182298 | ENA